AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 292: E1782-E1789, 2007. First published February 20, 2007; doi:10.1152/ajpendo.00639.2006
0193-1849/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/6/E1782    most recent
00639.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holloway, G. P.
Right arrow Articles by Spriet, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holloway, G. P.
Right arrow Articles by Spriet, L. L.

Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women

Graham P. Holloway,1 A. Brianne Thrush,1 George J. F. Heigenhauser,2 Narendra N. Tandon,3 David J. Dyck,1 Arend Bonen,1 and Lawrence L. Spriet1

1Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario; 2Department of Medicine, McMaster University, Hamilton, Ontario, Canada; and 3Thrombosis Research Laboratory, Otsuka Maryland Medicinal Laboratories, Rockville, Maryland

Submitted 22 November 2006 ; accepted in final form 4 February 2007

A reduction in fatty acid oxidation has been associated with lipid accumulation and insulin resistance in the skeletal muscle of obese individuals. We examined whether this decrease in fatty acid oxidation was attributable to a reduction in muscle mitochondrial content and/or a dysfunction in fatty acid oxidation within mitochondria obtained from skeletal muscle of age-matched, lean [body mass index (BMI) = 23.3 ± 0.7 kg/m2] and obese women (BMI = 37.6 ± 2.2 kg/m2). The mitochondrial marker enzymes citrate synthase (–34%), beta-hydroxyacyl-CoA dehydrogenase (–17%), and cytochrome c oxidase (–32%) were reduced (P < 0.05) in obese participants, indicating that mitochondrial content was diminished. Obesity did not alter the ability of isolated mitochondria to oxidize palmitate; however, fatty acid oxidation was reduced at the whole muscle level by 28% (P < 0.05) in the obese. Mitochondrial fatty acid translocase (FAT/CD36) did not differ in lean and obese individuals, but mitochondrial FAT/CD36 was correlated with mitochondrial fatty acid oxidation (r = 0.67, P < 0.05). We conclude that the reduction in fatty acid oxidation in obese individuals is attributable to a decrease in mitochondrial content, not to an intrinsic defect in the mitochondria obtained from skeletal muscle of obese individuals. In addition, it appears that mitochondrial FAT/CD36 may be involved in regulating fatty acid oxidation in human skeletal muscle.

obesity; mitochondria; fatty acid translocase/CD36; transport proteins


Address for reprint requests and other correspondence: G. Holloway, Dept. of Human Health & Nutritional Sciences, Univ. of Guelph, 50 Stone Rd., Guelph, Ontario, Canada N1G2W1 (e-mail: ghollowa{at}uoguelph.ca)




This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. P. Holloway, C. G. R. Perry, A. B. Thrush, G. J. F. Heigenhauser, D. J. Dyck, A. Bonen, and L. L. Spriet
PGC-1{alpha}'s relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1{alpha} and PGC-1{beta} protein
Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1060 - E1069.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
C. R. Benton, G. P. Holloway, S. E. Campbell, Y. Yoshida, N. N. Tandon, J. F. C. Glatz, J. J. J. F. P. Luiken, L. L. Spriet, and A. Bonen
Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria
J. Physiol., March 15, 2008; 586(6): 1755 - 1766.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
Arend. Bonen, Hideo. Hatta, G. P. Holloway, L. L. Spriet, and Y. Yoshida
Reply from Arend Bonen, Hideo Hatta, Graham P. Holloway, Lawrence L. Spriet and Yuko Yoshida
J. Physiol., October 15, 2007; 584(2): 707 - 708.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
X.-X. Han, A. Chabowski, N. N. Tandon, J. Calles-Escandon, J. F. C. Glatz, J. J. F. P. Luiken, and A. Bonen
Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle
Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E566 - E575.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.